Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 161-170 of 847 for cardiovascular

Edit search filters
  1. Myocardial Infarction Genes (MI-GENES) Study

    Rochester, MN

  2. A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

    Scottsdale/Phoenix, AZ

  3. The Effects of Acute and Chronic Exercise on the Immune Phenotype in Healthy Patients

    Rochester, MN

  4. Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

    Rochester, MN

  5. Saline-Enhanced Radiofrequency Catheter Ablation for the Treatment of Ventricular Tachycardia

  6. A Study to Assess the Effectiveness and Safety of Rilonacept Treatment in Subjects with Recurrent Pericarditis

    Rochester, MN

  7. A Study of the Long-Term Safety of Tafamidis for Patients with Transthyretin Cardiomyopathy

    Rochester, MN

  8. A Study of the Effectiveness and Safety of Rivaroxaban on Venous Thromboembolic Risk in Patients Following Hospital Discharge

  9. A Study for Sources of Pulmonary Congestion Associated with Heart Failure

    Rochester, MN

  10. A Study of the FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

    Rochester, MN

.

Mayo Clinic Footer